Skip to main content
. 1998 Apr 28;95(9):5317–5322. doi: 10.1073/pnas.95.9.5317

Table 1.

Minimal inhibitory concentrations of RWJ-49815 and analogs against Gram-positive bacteria

Minimal inhibitory concentrations,* μg/ml
Test organism RWJ-49815 RWJ-49619 RWJ-49640 RWJ-60953
S. aureus ATTC 29213 1 4 4 16
S. aureus ATTC 6538 2 2 1 >32
S. aureus OC667 (MR) 2 2 2 >32
S. aureus OC2089 (MR) 2 2 1 >32
S. epidermidis OC2603 2 2 2 >32
E. faecalis ATCC 29212 2 4 8 >32
E. faecalis OC3041 2 4 8 >32
E. faecium OC3312 (VanR) 1 4 8 >32
S. pneumoniae OC3570 (PenS) 2 16 8 >32
S. pneumoniae OC3561 (PenI) 2 8 4 >32
S. pneumoniae OC3035 (PenR) 1 8 4 >32
*

Stock solutions of the compounds were prepared in dimethyl sulfoxide at 2.56 mg/ml and MICs were determined with the broth micro-dilution method as described by the National Committee for Clinical Laboratory Standards (1994) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 

Molecular weights of compounds: RWJ-49815, 449; RWJ-49619, 407; RWJ-49640, 373; RWJ-60953, 466. MR, methicillin-resistant; VanR, vancomycin-resistant; PenS, penicillin-sensitive; PenI, intermediate penicillin-resistant; PenR, penicillin-resistant.